chartexchange

NeOnc Insider Buying Expands Ahead of FDA Discussions and Two Key Brain Cancer Data Presentations

GlobeNewswire Inc. | Nov 12, 2026 9:24 AM EST

Insiders continue to Buy NeOnc (NASDAQ: NTHI) as it heads into a potentially important period for its clinical programs and FDA meetings

Read original article